Rigel Pharmaceuticals reported $59.22M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acura Pharmaceuticals ACUR:US 1.11M 6.57M
Agenus AGEN:US $ 163.06M 6.12M
Amgen AMGN:US $ 12886M 702M
Anika Therapeutics ANIK:US $ 26.99M 2.8M
Applied Genetic Technologies AGTC:US $ 25.81M 1.7M
Arrowhead Research ARWR:US $ 138.86M 1.82M
AstraZeneca AZN:LN 22740M 146M
Astrazeneca AZN:US $ 22740M 146M
Biomarin Pharmaceutical BMRN:US $ 490.42M 49.4M
Bristol Myers Squibb BMY:US $ 22821M 953M
Celldex Therapeutics CLDX:US $ 14.56M 1.97M
Chemocentryx CCXI:US $ 68.81M 5.79M
Daiichi Sankyo 4568:JP Y 395268M 40073M
Eli Lilly And LLY:US $ 13386M 1666.7M
Halozyme Therapeutics HALO:US $ 111.69M 5.46M
Heron Therapeutics HRTX:US $ 93M 21.94M
Immunogen IMGN:US $ 84.12M 16.83M
Intrexon XON:US $ 25.6M 9.04M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Karyopharm Therapeutics KPTI:US $ 66.34M 7.38M
Ligand Pharmaceuticals LGND:US $ 42.58M 0.91M
Macrogenics MGNX:US $ 67.1M 7.48M
Neurocrine Biosciences NBIX:US $ 253.5M 7.7M
Pfizer PFE:US $ 39268M 3403M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M
Rigel Pharmaceuticals RIGL:US $ 59.22M 4.33M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M
Veracyte VCYT:US $ 62.54M 1.61M